Steven Stryker
Colon & Rectal Surgery · Chicago, ILNPI 1760448096
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,359 of the $11,379 with a category attached, or 64.7%. Baxter Healthcare accounts for 66.4% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2020 at $4,629 and has fallen 97.8% since, to $100 in 2025.
Across 133 payments — averaging $85.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$8K
- Intuitive Surgical$1K
- Braintree Laboratories, Inc.$240
- Boehringer Ingelheim$232
- Johnson & Johnson$229
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$220
- plus $2K from 24 others
What the payments were for
- Consulting fees$7,35965%
- Travel & lodging$7066%
- Food & beverage$3,30529%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 5 | $7,558 |
| Intuitive Surgical | 14 | $1,386 |
| Braintree Laboratories, Inc. | 14 | $240 |
| Boehringer Ingelheim | 12 | $232 |
| Johnson & Johnson | 9 | $229 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $220 |
| AbbVie(2 entities) | 4 | $176 |
| Conmed Corporation | 2 | $169 |
| Merck | 10 | $165 |
| Covidien LP | 1 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $131 |
| Eisai Inc. | 6 | $100 |
| IBSA Pharma Inc. | 6 | $97 |
| Novo Nordisk | 4 | $78 |
| Bausch Health US, LLC | 3 | $68 |
| Sanofi Pasteur Inc. | 3 | $65 |
| Amgen | 3 | $49 |
| Biohaven Pharmaceuticals, Inc. | 2 | $44 |
| Pacira Pharmaceuticals Incorporated | 2 | $35 |
| Integra Lifesciences Corporation | 1 | $28 |
| Amneal Pharmaceuticals LLC | 2 | $26 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Pfizer | 1 | $19 |
| Bristol Myers Squibb | 1 | $18 |
| Innocoll Pharmaceuticals Limited | 1 | $16 |
| Coopersurgical, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $11 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SEPRAFILM$7,359
- ADEPT$1,650
- Da Vinci Surgical System$874
- STRATTICE$110
- PerClot$100
How this compares
$11,379 in reported general payments places this provider in the 80th percentile of 79 colon & rectal surgery providers in Illinois.
Other colon & rectal surgery in Chicago
- Marc SingerChicago$201K
- Francisco QuinterosChicago$119K
- Konstantin UmanskiyChicago$30K
- Vitaliy PoylinChicago$26K
- Neil HymanChicago$20K
- Amy HalversonChicago$19K
- Gerald GanttChicago$16K
- Jacqueline HarrisonChicago$15K
- Scott StrongChicago$12K
- Anders MellgrenChicago$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.